Glow Blend

The GLOW blend formulation unites three of the most extensively studied tissue-repair peptides in preclinical literature. BPC-157 (Body Protection Compound-157) targets angiogenesis and connective tissue signaling. GHK-Cu (Glycyl-L-Histidyl-L-Lysine · Copper(II)) drives collagen synthesis and extracellular matrix remodeling. TB-500 (Thymosin Beta-4 fragment) promotes actin polymerization and cell migration. Together, these three compounds address complementary mechanisms that single-peptide protocols may not fully engage. Researchers studying multi-pathway skin regeneration, wound healing, or connective tissue repair will find this GLOW blend combination particularly relevant to their work.